BofA raised the firm’s price target on Cigna (CI) to $407 from $395 and keeps a Buy rating on the shares. Following the company’s Q1 report and guidance, the firm raised its estimates, stating that the guidance looks conservative. The firm sees Cigna as insulated from broader Medicaid/Medicare pressures and headlines, the analyst added.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CI:
- Cigna’s Strategic Innovations and Financial Resilience Justify Buy Rating
- Cigna price target raised to $382 from $339 at Barclays
- Cigna’s Strong Q1 Performance and Growth in Specialty Segments Drive Buy Rating
- Cigna Reports Strong Q1 2025 Results and Raises Outlook
- Cigna’s Earnings Call: Strong Growth and Strategic Innovations
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue